CN101301412B - Shuyu Sanjie Capsules - Google Patents
Shuyu Sanjie Capsules Download PDFInfo
- Publication number
- CN101301412B CN101301412B CN2008100500967A CN200810050096A CN101301412B CN 101301412 B CN101301412 B CN 101301412B CN 2008100500967 A CN2008100500967 A CN 2008100500967A CN 200810050096 A CN200810050096 A CN 200810050096A CN 101301412 B CN101301412 B CN 101301412B
- Authority
- CN
- China
- Prior art keywords
- breast
- capsules
- pericarpium citri
- citri reticulatae
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 29
- 239000003814 drug Substances 0.000 claims abstract description 18
- 239000000203 mixture Substances 0.000 claims abstract 5
- 239000009286 sanguis draxonis Substances 0.000 claims description 10
- 241000522620 Scorpio Species 0.000 claims description 9
- 239000009490 scorpio Substances 0.000 claims description 9
- 238000004659 sterilization and disinfection Methods 0.000 claims description 7
- 238000012856 packing Methods 0.000 claims description 6
- 210000000481 breast Anatomy 0.000 abstract description 22
- 230000005906 menstruation Effects 0.000 abstract description 12
- 239000008280 blood Substances 0.000 abstract description 11
- 210000004369 blood Anatomy 0.000 abstract description 11
- 230000000694 effects Effects 0.000 abstract description 10
- 208000002193 Pain Diseases 0.000 abstract description 9
- 206010046798 Uterine leiomyoma Diseases 0.000 abstract description 9
- 208000037093 Menstruation Disturbances Diseases 0.000 abstract description 8
- 206010008570 Chloasma Diseases 0.000 abstract description 7
- 208000005171 Dysmenorrhea Diseases 0.000 abstract description 7
- 206010013935 Dysmenorrhoea Diseases 0.000 abstract description 7
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 7
- 208000003351 Melanosis Diseases 0.000 abstract description 7
- 208000026435 phlegm Diseases 0.000 abstract description 7
- 238000002360 preparation method Methods 0.000 abstract description 5
- 230000001105 regulatory effect Effects 0.000 abstract description 5
- 230000008901 benefit Effects 0.000 abstract description 4
- 210000003734 kidney Anatomy 0.000 abstract description 4
- 231100000957 no side effect Toxicity 0.000 abstract description 4
- 208000017520 skin disease Diseases 0.000 abstract description 4
- 210000004185 liver Anatomy 0.000 abstract description 3
- 210000000952 spleen Anatomy 0.000 abstract description 3
- 206010006272 Breast mass Diseases 0.000 abstract description 2
- 229940079593 drug Drugs 0.000 abstract description 2
- 238000011160 research Methods 0.000 abstract description 2
- 201000010260 leiomyoma Diseases 0.000 abstract 2
- 206010006256 Breast hyperplasia Diseases 0.000 abstract 1
- 241000202726 Bupleurum Species 0.000 abstract 1
- 241000675108 Citrus tangerina Species 0.000 abstract 1
- 206010027339 Menstruation irregular Diseases 0.000 abstract 1
- 241000013557 Plantaginaceae Species 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 241000239226 Scorpiones Species 0.000 abstract 1
- 241000218989 Trichosanthes Species 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 230000003716 rejuvenation Effects 0.000 abstract 1
- 208000019255 Menstrual disease Diseases 0.000 description 16
- 210000005075 mammary gland Anatomy 0.000 description 12
- 230000003821 menstrual periods Effects 0.000 description 11
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 206010006298 Breast pain Diseases 0.000 description 6
- 208000006662 Mastodynia Diseases 0.000 description 6
- 230000027758 ovulation cycle Effects 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 206010021033 Hypomenorrhoea Diseases 0.000 description 5
- 206010016629 fibroma Diseases 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 206010006187 Breast cancer Diseases 0.000 description 4
- 208000026310 Breast neoplasm Diseases 0.000 description 4
- 239000011812 mixed powder Substances 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 208000007106 menorrhagia Diseases 0.000 description 3
- 206010036086 Polymenorrhoea Diseases 0.000 description 2
- 201000008275 breast carcinoma Diseases 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000000994 depressogenic effect Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000008451 emotion Effects 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000002547 anomalous effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明涉及疏郁散结胶囊，用于疏肝理气，醒脾化痰，祛瘀散结，补肾调经，可有效解决乳房胀痛，乳腺增生，乳房肿块，乳腺纤维瘤，子宫肌瘤，月经不调，痛经，黄褐斑等气滞痰阻血瘀性质的乳腺、月经及肌肤病症的问题，其解决的技术方案是，本发明胶囊是由柴胡2.5～3.5g、丹参15～20g、玄参5.5～6.5g、全蝎5.5～6.5g、陈皮8～10g、青皮8～10g、血竭5.5～6.5g、瓜蒌21～27g制成，将上述药物分别烘干，粉碎，混合粉末，过筛，装入胶囊，紫外线消毒即得。本发明药源丰富，制备工艺简便，易于携带，使用方便，价廉效佳，治疗面广，无副作用，其研究推广，有着良好的应用前景，必将产生较大的社会效益，并将为广大妇女解除痛苦。The invention relates to Shuyu Sanjie Capsules, which are used for soothing the liver and regulating qi, rejuvenating the spleen and resolving phlegm, dispelling blood stasis and dispelling stagnation, invigorating the kidney and regulating menstruation, and can effectively solve breast distending pain, breast hyperplasia, breast lump, breast fibroid, uterine fibroids, and irregular menstruation. Dysmenorrhea, breast, menstruation and skin diseases such as qi stagnation, phlegm and blood stasis properties such as chloasma, the technical solution is that the capsule of the present invention is composed of Bupleurum 2.5～3.5g, Salvia miltiorrhiza 15～20g, Scrophulariaceae 5.5-6.5g, 5.5-6.5g of scorpion, 8-10g of tangerine peel, 8-10g of green peel, 5.5-6.5g of dried blood, and 21-27g of Trichosanthes. Dry the above-mentioned medicines separately, crush them, mix the powder, and pass Sieve, pack into capsules, and sterilize with ultraviolet light. The present invention has rich sources of medicine, simple and convenient preparation process, easy to carry, convenient to use, low price and good effect, wide range of treatment, and no side effects. Its research and popularization have good application prospects, and will certainly produce greater social benefits, and will serve as The vast majority of women relieve pain.
Description
One, technical field
The present invention relates to medical domain, particularly a kind of capsules for soothing depression and dissipating binds.
Two, background technology
Breast symptom comprises that acute mastitis, chronic mastitis, cyclomastopathy, cyclomastopathy, cyclomastopathy, cystic hyperplasia of breast, mammary gland fibroma, tuberculosis of breast, breast are painful, distending pain of the breast, breast tumor and breast carcinoma etc. before and after the mastalgia, menstruation.Except breast carcinoma and part breast tumor, most of breast symptoms are optimum, but benign cyclomastopathy and fibroma also are converted into virulent possibility.Chinese medicine thinks that the mastotic cause of disease relates generally to factors such as emotion, diet, age, endocrine.Depressed rage impairing the liver is qi depression to blood stasis then; The worried impairment of the spleen is turbid interior the giving birth to of expectorant then; The retardance of the liver spleen expectorant stasis of blood is then dashed and is appointed the passages through which vital energy circulates imbalance; Involve in newborn network mammary gland, then cause cyclomastopathy, distending pain of the breast; Involve in the kidney channel vessels of the uterus, even then cause the menoxenia hysteromyoma; Cause in the stagnant heat toxin and accumulate, then cause diseases such as the yellowish-brown speckle of skin and manifest.In view of this, cyclomastopathy, hysteromyoma and yellowish-brown pinta are " different sick homology ".Since belong to different sick homology, need naturally " treating different diseases with the same therapeutic principle ".So how realize this purpose?
Three, summary of the invention
At above-mentioned situation, the present invention's purpose just is to provide a kind of capsules for soothing depression and dissipating binds, be used for depressed liver-energy dispersing and QI regulating, be amusing and reduce phlegm, eliminating stasis and resolving masses, invigorating kidney for regulating menstruation, can effectively solve distending pain of the breast, cyclomastopathy, lump in breast, mammary gland fibroma, hysteromyoma, menoxenia, dysmenorrhea, the mammary gland of stagnation of QI causing phlegm retention blood stasis character such as chloasma, the problem of menstruation and skin disease, the technical scheme of its solution is, capsule of the present invention is by Radix Bupleuri 2.5～3.5g, Radix Salviae Miltiorrhizae 15～20g, Radix Scrophulariae 5.5～6.5g, Scorpio 5.5～6.5g, Pericarpium Citri Reticulatae 8～10g, Pericarpium Citri Reticulatae Viride 8～10g, Sanguis Draxonis 5.5～6.5g, Fructus Trichosanthis 21～27g makes, and said medicine is dried respectively, pulverizes, mixed-powder, sieve, incapsulate, disinfection by ultraviolet light promptly.Medicine of the present invention source is abundant, and preparation technology is easy, is easy to carry about with one, and is easy to use, and inexpensive effect is good, treats widely, has no side effect, and its research promotion has good prospects for application, will produce bigger social benefit, and will remove misery for numerous women.
Four, the specific embodiment
Below in conjunction with embodiment the specific embodiment of the present invention is elaborated.
Embodiment 1, the present invention is made by Radix Bupleuri 2.5g, Radix Salviae Miltiorrhizae 15g, Radix Scrophulariae 5.5g, Scorpio 5.5g, Pericarpium Citri Reticulatae 8g, Pericarpium Citri Reticulatae Viride 8g, Sanguis Draxonis 5.5g, Fructus Trichosanthis 21g, said medicine is dried respectively, pulverize, mixed-powder is crossed 150 mesh sieves, the capsule of packing into No. 0, every content 0.5 gram, bottling back disinfection by ultraviolet light.
Embodiment 2, the present invention is made by Radix Bupleuri 3g, Radix Salviae Miltiorrhizae 18g, Radix Scrophulariae 6g, Scorpio 6g, Pericarpium Citri Reticulatae 9g, Pericarpium Citri Reticulatae Viride 9g, Sanguis Draxonis 6g, Fructus Trichosanthis 24g, said medicine is dried respectively, pulverize, mixed-powder is crossed 100 mesh sieves, the capsule of packing into No. 0, every content 0.5 gram, bottling back disinfection by ultraviolet light.
Embodiment 3, the present invention can also be that Radix Bupleuri 3.5g, Radix Salviae Miltiorrhizae 20g, Radix Scrophulariae 6.5g, Scorpio 6.5g, Pericarpium Citri Reticulatae 10g, Pericarpium Citri Reticulatae Viride 10g, Sanguis Draxonis 6.5g, Fructus Trichosanthis 27g make, said medicine is dried respectively, pulverize, mixed-powder is crossed 150 mesh sieves, the capsule of packing into No. 0, every content 0.5 gram, bottling back disinfection by ultraviolet light.
The scientific compatible combination of said medicine supports to have the hard masses softening and resolving removing food stagnancy each other on function, the function of lactogenesis menstruation-regulating and speckle-dispelling just in time reaches effective treatment distending pain of the breast, cyclomastopathy, lump in breast, mammary gland fibroma, hysteromyoma, menoxenia, dysmenorrhea, mammary gland, menstruation and the skin disease of stagnation of QI causing phlegm retention blood stasis character such as chloasma, and proved that by clinical practice the concrete relevant clinical data of capsule of the present invention is as follows:
One, selects the standard of case
With cyclomastopathy and menoxenia is example:
Cyclomastopathy is meant breast epithelium and proliferation of fibrous tissue, is one of common gynecological disease.Can one-sided morbidity or bilateral fall ill simultaneously, the performance that cyclomastopathy is outstanding has lump in distending pain of the breast and the breast.
Menoxenia mainly is meant cycle, the menstrual period and unusual through what measure of menstruation, comprises epimenorrhea, i.e. the menstruation cycle is shorter than 21 days; Irregular menses, i.e. the menstruation cycle shifts to an earlier date 7 days or delays more than 7 days; Hypomenorrhea, i.e. the menstruation cycle was above 40 days; Menstrual period are long, and promptly menstrual period was above 7 days; Menorrhagia, i.e. menorrhagia; Hypomenorrhea, the front-month hypomenorrhea, even drop is promptly clean.
Two, diagnostic criteria
With cyclomastopathy and menoxenia is example:
The diagnostic criteria of cyclomastopathy is as follows:
1. single or multiple lumps appear in the one or both sides breast, and distending pain of the breast has obvious relation with emotion and menstrual cycle, can not alleviate in continuous three months;
2. get rid of the physiological mastalgia, the physiological mastalgia does not have the performance of breast lump;
3. can touch lump in the clinical health check-up breast, single or multiple, matter is tough, differs in size, and is irregular, multidigit in outside go up quadrant, lump and surrounding tissue do not have adhesion, can be pushed, the slight tenderness, the axillary lymph knot is not quite;
4. molybdenum target X line or color ultrasound are assisted diagnosis, go suction cytolgical examination of lump pin or local organization biopsy in case of necessity to make a definite diagnosis.
The diagnostic criteria of menoxenia is as follows:
1. epimenorrhea, menstrual cycle foreshortens to the person of promptly not rising about 20 days.
2. hypomenorrhea, menstrual cycle extended to more than 40 days, even 2～3 months persons of not rising once.
3. irregular menses is a tide about 20 days during menstrual cycle, the time be a tide about 40 days, successively do not have regularly.
4. menstrual period long, surpass 7 days menstrual period, very then the clean person of talent surplus in the of 10.
5.. menorrhagia, menstrual cycle, menstrual period are all normal, but menstrual blood volume showed increased more in the past, even along lower limb stream person.
6.. hypomenorrhea, menstrual cycle is normal, but menstrual blood volume more obviously reduces, obviously shortens menstrual period or drop is clean person.
Three, therapeutic scheme
The patient takes capsule of the present invention, and each 3～6, every day 2 times, the empty stomach warm water delivery service, per 2 weeks were 1 course of treatment.Observe clinical symptoms change before and after taking the present invention, judge curative effect.
Contraindication: menstrual period and pregnancy period forbidding.
Four, efficacy assessment standard
The criterion of therapeutical effect of cyclomastopathy:
1. complete obiteration of produce effects mammary gland tumor and mastalgia complete obiteration;
2. effective mammary gland tumor is dwindled more than 1/3 and mastalgia obviously alleviates;
3. invalid mammary gland tumor does not have significant change or mastalgia and does not have obviously and alleviate.
The criterion of therapeutical effect of menoxenia:
1. produce effects menstrual period, cycle, recover normal fully through the symptom of amount or dysmenorrhea;
2. effectively menstrual period, cycle, obviously alleviate through the symptom of amount or dysmenorrhea, and progressively alleviate more than two months;
3. invalid menstrual period, cycle, there is not obvious alleviator through the symptom of amount or dysmenorrhea.
Five, statistical disposition
By above-mentioned therapeutic scheme, diseases such as treatment cyclomastopathy or double menoxenia, wherein observe cyclomastopathy 947 examples, menoxenia 363 examples, the patient of 947 routine cyclomastopathy serves as to observe the time limit with the capsules for soothing depression and dissipating binds of the present invention of taking two courses of treatment all, in 947 routine patients of cyclomastopathy, there are 363 routine patients that the disease of menoxenia is arranged simultaneously, account for cyclomastopathy patient's 38.33%.These suffer from the patient of cyclomastopathy and two kinds of diseases of menoxenia simultaneously, and in the process of treatment cyclomastopathy, most of patient's menoxenia alleviates and alleviates with cyclomastopathy, and its total effective rate is respectively 98.34% and 94.54%.
Its result respectively as shown in Table 1 and Table 2.
The curative effect of table 1 capsules for soothing depression and dissipating binds treatment of the present invention cyclomastopathy
The curative effect of table 2 capsules for soothing depression and dissipating binds treatment of the present invention menoxenia
Among the 947 routine cyclomastopathy patients of clinical observation, there is the part patient to suffer from hysteromyoma simultaneously, also have the part patient to suffer from chloasma faciei simultaneously, the hysteromyoma that wherein has dwindles, the chloasma that has disappears, and illustrates that capsules for soothing depression and dissipating binds of the present invention can treat the multiple disease of cyclomastopathy, menoxenia, hysteromyoma and chloasma faciei to a certain extent simultaneously.
All take the patient of capsules for soothing depression and dissipating binds of the present invention, and at whole period in a medicine, none example occurs that the diarrhoea reaction appears in anaphylaxis, none example, uncomfortable reaction such as weak or poor appetite appears in none example; Part patient is through chemical examination monitorings such as routine blood test, routine urinalysis, stool routine, liver function and renal functioies before and after the treatment, and ANOMALOUS VARIATIONS appears in none example, and capsules for soothing depression and dissipating binds of the present invention is not only effective, and has no side effect, and is as safe as a house.
Observe from iconography, take the cyclomastopathy patient of capsules for soothing depression and dissipating binds of the present invention after two courses of treatment, its produce effects person's mammary gland luminous point become clear, even, yellowish orange, two newborn blood vessels are even, on slightly extend and attenuate smooth-shaped, nature out of shape to two lower limits, compare to the iconography before the treatment, its variation shows that cyclomastopathy recovered normal.
In sum, in the capsules for soothing depression and dissipating binds of the present invention, the Radix Bupleuri Pericarpium Citri Reticulatae Viride is with liver-smoothing, qi-regulating, and the Pericarpium Citri Reticulatae Fructus Trichosanthis is with eleminating phlegm and freeing channels, and the Radix Salviae Miltiorrhizae Sanguis Draxonis is with blood circulation promoting and blood stasis dispelling, and the Radix Scrophulariae Scorpio is with hard masses softening and resolving, and the Radix Bupleuri Radix Scrophulariae is with heat-clearing and toxic substances removing, Radix Scrophulariae Sanguis Draxonis invigorating kidney for regulating menstruation; Full side's scientific combination is supported hard masses softening and resolving removing food stagnancy, lactogenesis menstruation-regulating and speckle-dispelling mutually on the function, can be effective to treat distending pain of the breast, cyclomastopathy, lump in breast, mammary gland fibroma, hysteromyoma, menoxenia, dysmenorrhea, mammary gland, menstruation and the skin disease of stagnation of QI causing phlegm retention blood stasis character such as chloasma.The present invention is in conjunction with the clinical application experience, and the Chinese patent medicine preparation through scientific technology processes does not have irritated reaction and toxic and side effects to body.As Chinese medicine preparation, its medicine source is abundant, and preparation technology is easy, be easy to carry about with one, easy to use, inexpensive effect is good, treat wide, have no side effect, evident in efficacy, the succeeding in developing of capsules for soothing depression and dissipating binds of the present invention, clinical practice, apply, for numerous women remove misery, will produce good social benefit and economic benefit, be a creation on the Chinese medicine and pharmacy.
Claims (4)
1. capsules for soothing depression and dissipating binds, it is characterized in that, make by Radix Bupleuri 2.5～3.5g, Radix Salviae Miltiorrhizae 15～20g, Radix Scrophulariae 5.5～6.5g, Scorpio 5.5～6.5g, Pericarpium Citri Reticulatae 8～10g, Pericarpium Citri Reticulatae Viride 8～10g, Sanguis Draxonis 5.5～6.5g, Fructus Trichosanthis 21～27g, said medicine is dried respectively, pulverize, mix, incapsulate.
2. capsules for soothing depression and dissipating binds according to claim 1, it is characterized in that, make by Radix Bupleuri 2.5g, Radix Salviae Miltiorrhizae 15g, Radix Scrophulariae 5.5g, Scorpio 5.5g, Pericarpium Citri Reticulatae 8g, Pericarpium Citri Reticulatae Viride 8g, Sanguis Draxonis 5.5g, Fructus Trichosanthis 21g, said medicine is dried respectively, pulverize, mix, cross 150 mesh sieves, the capsule of packing into No. 0, every content 0.5 gram, bottling back disinfection by ultraviolet light.
3. capsules for soothing depression and dissipating binds according to claim 1, it is characterized in that, make by Radix Bupleuri 3g, Radix Salviae Miltiorrhizae 18g, Radix Scrophulariae 6g, Scorpio 6g, Pericarpium Citri Reticulatae 9g, Pericarpium Citri Reticulatae Viride 9g, Sanguis Draxonis 6g, Fructus Trichosanthis 24g, said medicine is dried respectively, pulverize, mix, cross 100 mesh sieves, the capsule of packing into No. 0, every content 0.5 gram, bottling back disinfection by ultraviolet light.
4. capsules for soothing depression and dissipating binds according to claim 1, it is characterized in that, make by Radix Bupleuri 3.5g, Radix Salviae Miltiorrhizae 20g, Radix Scrophulariae 6.5g, Scorpio 6.5g, Pericarpium Citri Reticulatae 10g, Pericarpium Citri Reticulatae Viride 10g, Sanguis Draxonis 6.5g, Fructus Trichosanthis 27g, said medicine is dried respectively, pulverize, mix, cross 150 mesh sieves, the capsule of packing into No. 0, every content 0.5 gram, bottling back disinfection by ultraviolet light.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008100500967A CN101301412B (en) | 2008-06-20 | 2008-06-20 | Shuyu Sanjie Capsules |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008100500967A CN101301412B (en) | 2008-06-20 | 2008-06-20 | Shuyu Sanjie Capsules |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101301412A CN101301412A (en) | 2008-11-12 |
| CN101301412B true CN101301412B (en) | 2010-09-15 |
Family
ID=40111629
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008100500967A Expired - Fee Related CN101301412B (en) | 2008-06-20 | 2008-06-20 | Shuyu Sanjie Capsules |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101301412B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104398713A (en) * | 2014-11-14 | 2015-03-11 | 魏勤友 | Chinese medicinal composition for eliminating breast lumps, breast hyperplasia and mastadenoma |
-
2008
- 2008-06-20 CN CN2008100500967A patent/CN101301412B/en not_active Expired - Fee Related
Non-Patent Citations (1)
| Title |
|---|
| 国家药品监督管理局.消乳散结胶囊.国家中成药标准汇编，中成药地方标准上升国家标准部分，外科妇科分册.2002,138. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101301412A (en) | 2008-11-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101411848B (en) | Black plaster for treating gland hyperplasia and preparation method thereof | |
| CN102908603B (en) | Chinese medicament for treating hyperplasia of mammary glands | |
| CN105816806A (en) | Traditional Chinese medicine preparation for treating thyroid nodule | |
| CN103948782B (en) | Pharmaceutical composition for treating hyperplasia of mammary glands due to stagnation of liver qi as well as preparation method and application of pharmaceutical composition | |
| CN103585586A (en) | Traditional Chinese medicine composition for treating uterine fibroids and preparation method of same | |
| CN103393989A (en) | Traditional Chinese medicine composition for treating gynecologic inflammation | |
| CN102600432B (en) | Traditional Chinese medicine for treating hyperplasia of mammary glands | |
| CN100398141C (en) | Medicine for treating hyperplasia of mammary glands and preparation method thereof | |
| CN100369626C (en) | Traditional Chinese medicine capsule for treating mammary gland diseases | |
| CN103212047A (en) | Traditional Chinese medicine composition for treating hysteromyoma and ovarian cysts | |
| CN101301412B (en) | Shuyu Sanjie Capsules | |
| CN102755515B (en) | Traditional Chinese medicine decoction for treating hyperplasia of mammary glands | |
| CN106039151A (en) | External use ointment for treating hyperplasia of mammary glands | |
| CN101396534B (en) | Traditional Chinese medicine for treating lobular hyperplasia of mammary gland | |
| CN105853930A (en) | Traditional Chinese medicine composition for treating depression | |
| CN106266931A (en) | A kind of Chinese medicine composition treating gynecological tumor and preparation method thereof | |
| CN101085303A (en) | Oral administration traditional Chinese medicine composition for treating hyperplasia of mammary glands | |
| CN104623450A (en) | Traditional Chinese medicine preparation for treating breast cancer | |
| CN103893480A (en) | Traditional Chinese medicine preparation for treating kidney deficiency and blood stasis type oviduct obstructive infertility | |
| CN104857446B (en) | It is a kind of to treat cardiopathic Chinese medicine and preparation method thereof | |
| CN103877282A (en) | Traditional Chinese medicine preparation for treating salpinx obstructive infertility caused by accumulation and stasis of damp-heat | |
| CN103816339A (en) | Traditional Chinese medicine granule for treating liver stagnation phlegm stasis type breast hyperplasia | |
| CN103212030A (en) | Traditional Chinese medicine for treating liver depression type hyperplasia of mammary glands and preparation method thereof | |
| CN102283973A (en) | Traditional Chinese medicine plaster for treating benign tumor and reducing weight and preparation method thereof | |
| CN101214298B (en) | Externally-applied pharmaceutical composition for treating mazopathy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Lu Wanqiang Inventor after: Wang Huiqin Inventor after: Zheng Jiao Inventor before: Lu Wanqiang Inventor before: Zheng Jiao |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: LU WANQIANG ZHENG JIAO TO: LU WANQIANG WANG HUIQIN ZHENG JIAO |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100915 Termination date: 20130620 |